Abgenix, Inc.
🏢 View company profile →38Patents
4Active
38Granted
37Portfolio score
Filing activity: Jul 30, 1992 → Oct 4, 2006 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5939598A | Method of making transgenic mice lacking endogenous heavy chains | Chemistry; Metallurgy | 997 | Expired |
| US6075181A | Human antibodies derived from immunized xenomice | Chemistry; Metallurgy | 995 | Expired |
| US6150584A | Human antibodies derived from immunized xenomice | Chemistry; Metallurgy | 882 | Expired |
| US6114598A | Generation of xenogeneic antibodies | Chemistry; Metallurgy | 607 | Expired |
| US6162963A | Generation of Xenogenetic antibodies | Chemistry; Metallurgy | 532 | Expired |
| US5916771A | Production of a multimeric protein by cell fusion method | Chemistry; Metallurgy | 388 | Expired |
| US6235883A | Human monoclonal antibodies to epidermal growth factor receptor | Chemistry; Metallurgy | 346 | Expired |
| US6673986B1 | Generation of xenogeneic antibodies | Chemistry; Metallurgy | 277 | Expired |
| US6130364A | Production of antibodies using Cre-mediated site-specific recombination | Chemistry; Metallurgy | 275 | Expired |
| US6091001A | Production of antibodies using Cre-mediated site-specific recombination | Chemistry; Metallurgy | 223 | Expired |
| US6682736B1 | Human monoclonal antibodies to CTLA-4 | Chemistry; Metallurgy | 218 | Expired |
| US5985615A | Directed switch-mediated DNA recombination | Chemistry; Metallurgy | 164 | Expired |
| US5998209A | Generation of large genomic DNA deletions | Chemistry; Metallurgy | 155 | Expired |
| US6833268B1 | Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions | Chemistry; Metallurgy | 127 | Expired |
| US6657103B1 | Human antibodies derived from immunized xenomice | Chemistry; Metallurgy | 126 | Expired |
| US7064244B2 | Transgenic mammals having human Ig loci including plural VH and VK regions and antibodies produced therefrom | Chemistry; Metallurgy | 107 | Expired |
| US7288251B2 | Antibodies to CD40 | Chemistry; Metallurgy | 94 | Expired |
| US7049426B2 | Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions | Chemistry; Metallurgy | 63 | Expired |
| US7037498B2 | Antibodies to insulin-like growth factor I receptor | Physics | 62 | Expired |
| US7338660B2 | Methods of treating cancer and enhancing immune responses with antibodies that bind CD40 | Chemistry; Metallurgy | 61 | Active |
| US6458592B1 | Production of antibodies using cre-mediated site-specific recombination | Chemistry; Metallurgy | 54 | Expired |
| US7109003B2 | Methods for expressing and recovering human monoclonal antibodies to CTLA-4 | Chemistry; Metallurgy | 51 | Expired |
| US7145056B2 | Production of antibodies using cre-mediated site-specific recombination | Chemistry; Metallurgy | 50 | Expired |
| US6420140B1 | Production of multimeric protein by cell fusion method | Chemistry; Metallurgy | 44 | Expired |
| US7422742B2 | Methods for using human monoclonal antibodies to interleukin-5 | Chemistry; Metallurgy | 44 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.